Items Tagged ‘zoladex’

June 30th, 2014

Zoladex Shows Fertility Advantages in Treatment of Early Breast Cancer


At the 2014 American Society of Clinical Oncology® meeting in Chicago, researchers reported that women with early stage hormone receptor-negative (HR-negative) breast cancer who were treated with Zoladex® (goserelin) had a reduced rate of ovarian failure at 2 years. In addition, the Zoladex group had higher rates of patients becoming pregnant, patients giving birth, and […]

View full entry

Tags: Breast Cancer, Carcinoma In Situ Breast cancer, fertility, News, Stage I Node Negative Breast Cancer, Stages II-III Breast Cancer, zoladex